Improvements in Patient-Reported Outcomes After 12 Months of Maintenance Therapy With Cabotegravir + Rilpivirine Long-Acting Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide in the Phase 3b SOLAR Study - Mussini, Cristina; Cazanave, Charles; Adachi, Eisuke; Eu, Beng; Alonso, Marta Montero; Crofoot, Gordon; Chounta, Vasiliki; Kolobova, Irina; Sutton, Kenneth; Sutherland-Phillips, Denise; Urbaityte, Rimgaile; Ehmann, Alice; et al. (AIDS and Behavior, 2024)